ROME – Parkinson’s second neurodegenerative disease in the world after Alzheimer’s

Fitmapped  » Blog »  ROME – Parkinson’s second neurodegenerative disease in the world after Alzheimer’s
0 Comments

Roma – Parkinson’s, second neurodegenerative disease in the world after Alzheimer’s

Every year in Italy about 6.000 people are affected by Parkinson’s disease and in one case out of five they are less than 50 years old. Staying active as long as possible can prevent Parkinson’s and, together with the most advanced therapies and a multidisciplinary approach, it can help slow down the progression of the disease and improve the quality of life in all its phases. This is the key message of the National Parkinsonon day which is celebrated on November 28th and which was born with the aim of raising public awareness of the second most widespread neurodegenerative pathology after Alzheimer.

Also this year theIRCCS San Raffaele Pisana adheres to the day, with the staff of the Center for the study and care of Parkinsonon and movement disorders, directed by prof. Fabrizio Stocchi: “We decided to take to the streets – said the doctor – Bringing the knowledge of Parkinson’s even outside the hospital walls, approaching us who lives Parkinson’s lives every day and to those who do not know him “.

The appointment is for Friday 27 November 2015 from 5pm.30 at 21.30 in Piazza San Silvestro n. 28, Rome. During the meeting, the activities of the Parkinson’s Center and the team of doctors, neuropsychologists, nurses, physiotherapists and speech therapists of the IRCCS San Raffaele Pisana in Rome will be illustrated. on the disease. An exhibition of works created by Parkinsonian patients and offered a small refreshment will also be set up.

PARKINSON IN NUMBERS – According to a recent study, Parkinson’s, the second most prevalent degenerative disease after Alzheimer’s, affects around 250 people in Italy.000 people, a number destined to double in the next 15 years since every year there are about 6.000 new cases, with 1.5 to 2 times higher incidence in men than women. Although Parkinson’s is often mislabelled as a disease of old age, one in five people is under the age of 50 at the onset of initial symptoms. The warning signs of the disease are fatigue in walking, movement disorders and loss of balance, sometimes tremors. The annual cost per patient suffering from the disease of Parkinsons varies between 3.500 and 4.800 euros for the NHS, between 1.500 and 2.700 euros for the sick and between 10.000 and 17.000 euros for the company.

Reporting these data to the number of people with disease Parkinson Present in Italy, it has been calculated that the total load for the NHS, relating to this pathology, is between 1.1 and 1.3 billion euros and that for the company between 2.2 and 2.9 billion euros.